CD4 and Miyoshi myopathy: found that checkpoint molecules of PD-1, Tim-3 and LAG-3 were not persistently upregulated on CD4+ and CD8+ T cells after anti-BCMA BiTE® AMG 701 treatment in MM cells [24].